The forthcoming RayCare OIS from RaySearch will be web-based to more easily connect all members of the patient care team throughout a comprehensive cancer center
User's of Varian's 360 Oncology platform can see all of their current patients and associated tasks at a glance when they log in

Cancer is perhaps the most highly personal, complex disease in our world today. While the various types of cancer are well-established, no two cases are ever the same. Because of this, a multidisciplinary approach is often required, with a healthcare team assembled from across the hospital. Oncology information systems (OIS), also called oncology information management systems (OIMS), are designed to help coordinate care among providers.

University Medical Center Groningen (UMCG) is one of the largest hospitals in the Netherlands. The hospital provides world-class patient care and is engaged in cutting-edge scientific research and medical education. UMCG is a leading cancer center and will soon open a new state-of-the-art proton therapy center. 

The ITN team recently attended the Association for Medical Imaging Management (AHRA)’s 45th Annual Meeting and Exposition in Anaheim, Calif., where nearly 1,000 members, vendors and presenters came together to learn and network. We learned from the three nationally renowned keynote speakers, more than 100 breakout sessions and from the new technology showcased in the exhibit hall by 160 different companies.

Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology and has prompted the implementation of radiation dose monitoring systems.

Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology and has prompted the implementation of radiation dose monitoring systems. Prior to these systems, dose measurements either were not tracked or required manual calculation of dose based on scanner data in the DICOM headers. 

September 7, 2017 — Sapheneia and Scannerside received U.S. Food and Drug Administration (FDA) 510(k) clearance to market their XR-29 DoseCheck solution.

The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) on Sept. 8 to discuss regulatory approaches for use of gadolinium-based contrast agents (GBCAs).

September 7, 2017 — Median Technologies announced that it will lead a scientific and medical roundtable on Sept. 7 in Sophia-Antipolis, France, to discuss the application of its next-generation imaging platform iBiopsy for nonalcoholic steatohepatitis (NASH). The roundtable panel will include four key opinion leaders:

September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now